Re: Still waiting for that BETonMACE CKD sub-study 7 months later
posted on
Jun 12, 2020 01:58PM
jonzobot
in addition to the points you make in your post, depending on trial size, design, endpoints, etc, I believe we will have an opportunity for an early trial halt due to overwhelming efficacy. So maybe not as long and as expensive as we fear. I think this is one of the great features/benefits of the BTD...?